Efficacy and Safety of Adalimumab Long-Term Administration with Immunosuppressants at Juvenile Idiopathic Arthritis without Systemic Manifestations

Background: Treatment of patients with juvenile idiopathic arthritis (JIA) is one of the most complex and urgent problems of rheumatology.Objective: Our aim was to evaluate the efficacy and safety of adalimumab therapy combined with immunosuppressants in patients with JIA without systemic manifestat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: E. I. Alexeeva, T. M. Bzarova, S. I. Valieva, R. V. Denisova, K. B. Isaeva, E. G. Chistyakova, A. M. Chomakhidze, T. V. Sleptsova, N. I. Taibulatov, A. N. Fetisova, M. Sh. Shingarova
Format: Artigo
Idioma:Inglês
Publicat: "Paediatrician" Publishers LLC 2015-09-01
Col·lecció:Voprosy Sovremennoj Pediatrii
Matèries:
children
juvenile idiopathic arthritis
adalimumab
methotrexate
efficacy
safety
Accés en línia:https://vsp.spr-journal.ru/jour/article/view/1076
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars